Cingulate CING
NASDAQ CING
$5.55 +0.22 (+4.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cingulate (CING) Return on Capital Employed Growth (3y) (2025 - 2026)

Cingulate (CING) Return on Capital Employed Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -356.00
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -516.00
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -4,078.00
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 4,967.00
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 5,777.00
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -9,445.00
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 109.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - 513.00
10 Cingulate 72.85 Mn 72.85 Mn - -52,890.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -52,890.00
Dec 31, 2025 -59,119.00
Mar 31, 2025 -7,570.00